         In the United States Court of Federal Claims
                                 OFFICE OF SPECIAL MASTERS
                                          No. 17-209V
                                      (not to be published)

    ************************* *
                                            *
    PETER LONG III, Personal Representative *
                                            *
    of the Estate of Peter Long Jr.,        *             Filed: March 24, 2020
                                            *
                            Petitioner,     *
                                            *
                                            *             Decision by Stipulation; Damages;
    v.                                      *             Influenza Vaccine; Guillain-Barré
                                            *             Syndrome (“GBS”).
    SECRETARY OF HEALTH AND                 *
    HUMAN SERVICES,                         *
                                            *
                                            *
                            Respondent.     *
                                            *
    ************************* *

Howard Gold, Gold Law Firm, LLC, Wellesley Hills, MA, for Petitioner.
Adriana Teitel, U.S. Department of Justice, Washington, DC, for Respondent.

                              DECISION ON JOINT STIPULATION 1

        On February 13, 2017, Peter Long Jr. (“PLJ”) filed a petition, seeking compensation under
the National Vaccine Injury Compensation Program (“the Vaccine Program”).2 Pet., ECF No. 1.
Peter Long III (“Petitioner”) became the Personal Representative of PLJ’s estate on December 4,
2017. See Ex. 14. I issued an order to change the case caption on March 19, 2018. ECF No. 30.
Petitioner alleges PLJ developed Guillain-Barré syndrome (“GBS”) as a result of the influenza
vaccination PLJ received on October 27, 2015. See Stipulation ¶ 2, 4, dated March 24, 2020 (ECF

1
  Although this Decision has been formally designated “not to be published,” it will nevertheless be posted
on the Court of Federal Claims’ website in accordance with the E-Government Act of 2002, 44 U.S.C. §
3501 (2012). This means the ruling will be available to anyone with access to the internet. As provided
by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the Decision’s inclusion of certain
kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days
within which to request redaction “of any information furnished by that party: (1) that is a trade secret or
commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or
similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine
Rule 18(b). Otherwise, the Decision in its present form will be available. Id.
2
 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood
Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C.A. ' 300aa-
10-' 300aa-34 (West 1991 & Supp. 2002). All citations in this decision to individual sections of the Vaccine
Act are to 42 U.S.C.A. ' 300aa.
No. 56); see also Petition. Petitioner also alleges that PLJ’s GBS contributed to his death.
Stipulation ¶ 4.

        Respondent denies “that the flu vaccine caused PLJ’s alleged GBS, any other injury, or his
death.” See Stipulation ¶ 6. Nonetheless, both parties, while maintaining their above-stated
positions, agreed in a stipulation filed March 24, 2020 that the issues before them can be settled
and that a decision should be entered awarding Petitioner compensation.

        I have reviewed the file, and based upon that review, I conclude that the parties’ stipulation
is reasonable. I therefore adopt it as my decision in awarding damages on the terms set forth
therein.

       The stipulation awards:

       a lump sum of $225,000.00 in the form of a check payable to [P]etitioner as the personal
       representative of the estate of Peter Long Jr.

Stipulation ¶ 8. This award represents compensation for all damages that would be available under
42 U.S.C. § 300aa-15(a).

        I approve a Vaccine Program award in the requested amount set forth above to be made to
Petitioner. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk
of the Court is directed to enter judgment herewith.3

       IT IS SO ORDERED.
                                                              s/ Katherine E. Oler
                                                              Katherine E. Oler
                                                              Special Master




3
  Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by jointly filing notice
renouncing their right to seek review.
